Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT02472860
Eligibility Criteria:
Inclusion Criteria:
1. Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 ASD or previously diagnosed DSM-IV autistic disorder, Asperger's disorder or pervasive developmental disorder not otherwise specified (NOS) and who continue to manifest symptoms in core domains
2. Current ASD symptomatology at time of enrollment
3. Evidence of decrements in at least one of three target cognitive domains (mental flexibility/abstraction, working memory, or attention).
Exclusion Criteria:
1. Intellectual Disability
2. A known comorbid neurodevelopmental disorder with possible association with autism (i.e., fragile X syndrome, tuberous sclerosis, Angelman syndrome, Prader-Willi syndrome, Williams syndrome, neurofibromatosis, mitochondrial disorder).
3. Nonverbal or minimal verbal ability
4. No computer/internet connection at home
5. No family member with e-mail
6. Patients likely to have a change in therapeutic treatments within the next 6 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
17 Years
Study:
NCT02472860
Study Brief:
Protocol Section:
NCT02472860